Application of Patient Blood Management in the Oncology Patient Affected by Breast Cancer

This study is testing a blood management approach — including iron infusions — to optimize the health of breast cancer patients before and after surgery, reducing the need for blood transfusions. It focuses on patients with low iron or low hemoglobin levels. **You may be eligible if...** - You are over 18 years old - You have a confirmed breast cancer diagnosis - You may or may not have had chemotherapy before surgery - You are scheduled for breast surgery (with or without reconstruction) - Your hemoglobin is 11 g/dL or lower, and/or your iron transferrin saturation is 20% or lower **You may NOT be eligible if...** - You have a known allergy to ferric carboxymaltose (the iron infusion used in this study) - Your ferritin level is above 500 ng/mL (already iron-overloaded) - You are unable to sign consent or follow study procedures Talk to your doctor to see if this trial is right for you.